Prevalence of Sinonasal Cancer in Dr. Sardjito General Hospital Yogyakarta in The Period between January 2017 and December 2022
Abstract
Background: Sinonasal cancer is considered a rare disease and data concerning the disease in Indonesia still requires extensive research. This study aimed to describe the factors that contribute to the incidence and outcome of sinonasal cancer.
Methods: This was a descriptive study conducted at the Department of Otorhinolaryngology, Head and Neck Surgery, Dr. Sardjito General Hospital Yogyakarta between January 2017 and December 2022. Data regarding histopathological type, sex, age, location of tumor, presence of metabolic syndrome, staging, treatment, overall survival, and cancer recurrence were extracted from the patient’s medical records. All patients diagnosed with sinonasal cancer within the period were included in the study.
Results: A total of 117 patients were included in this study ranging from 11 to 85 years of age and averaging 54,5 years. Most patients were diagnosed within the age range of 51 – 60 years. SCC was found to be the most common and it was more prevalent in males than in females. More patients were found to have suprastructure tumors. Most patients were not recorded to have metabolic syndrome. The majority of patients were diagnosed in the late stage of sinonasal cancer and overall survival for most cases was death. More patients received 2 or less therapy, followed by patients who received all 3 types of treatment. Recurrency was found in only 1,7% of all cases.
Conclusion: Several conditions can affect the incidence and outcome of sinonasal cancer which include sex, age of diagnosis, presence of risk factors (e.g. metabolic syndrome), location of tumor, staging, treatment, recurrence, and the histopathological type.
Keywords
DOI: 10.33371/ijoc.v18i2.1087
Article Metrics
Abstract View: 200, 
PDF Download: 86
References
Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: A historical analysis of population-based data. Head and Neck. 2012;34(6):877–885.
Miligi L, Buzzoni C, Piro S. Epidemiology of Sinonasal Cancer. Pathology of Sinonasal Tumors and Tumor-Like Lesions. 2019.
Roezin A. Tumor Hidung dan Sinonasal. In: Soepardi EA, Iskandar N, Bashiruddin J, Restuti RD, editors. Buku Ajar Ilmu Kesehatan Telinga Hidung Tenggorokan Kepala & Leher. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2017
Shavilla E, Aroeman NA, Dewi YA, Permana AD. Prevalensi Kanker Sinonasal di Poliklinik THT-KL RS.Hasan Sadikin Bandung, Januari 2013-Juli 2015. 2016.
Kazi M, Awan S, Junaid M, et al. Management of Sinonasal Tumors: Prognostic Factors and Outcomes: A 10 Year Experience at a Tertiary Care Hospital. Indian Journal of Otolaryngology and Head and Neck Surgery. 2013;65(1):155–159.
Haerle SK, Gullane PJ, Witterick IJ, et al. Sinonasal Carcinomas. Epidemiology, Pathology, and Management. Neurosurgery Clinics of North America. 2013;24(1):39–49.
Barnes L, Eveson JW, Reichart P, Sidransky D. Tumours of the Nasal Cavity and Paranasal Sinuses. In: World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. p. 9–80.
Öhngren G. Malignant Disease of the Upper Jaw: (Section of Laryngology and Section of Otology). Proc R Soc Med. 1936;29(11):1497–514.
Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364–373.
Perri F, Addeo R, Conson M, et al. Locally advanced paranasal sinus carcinoma: A study of 30 patients. Oncol Lett. 2017;13(3):1338–1342.
Dhanani R, Faisal M, Shahid H, et al. Outcomes of management of sinonasal malignancies at a dedicated cancer institution: A retrospective study. Annals of Maxillofacial Surgery. 2021;11(1):115–120.
Youlden DR, Cramb SM, Peters S, et al. International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiology. 2013;37(6):770–779.
Bashjawish B, Patel S, Kılıç S, et al. Effect of elderly status on postoperative complications in patients with sinonasal cancer. Int Forum Allergy Rhinol. 2019;9(2):220–224.
Dagan R, Amdur RJ, Dziegielewski PT. Tumors of the nasal cavity. In: Brockstein BE, Posner MR, Brizel DM, Fried MP, Shah S, editors. UpToDate. 2023
Shah J, Bhuvanesh S, Patel S, Wong R. Jatin Shah’s Head and Neck Surgery and Oncology. 2020
Jiang H, Zhou L, He Q, et al. The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study. Cancer Metab. 2021;9(1).
Llorente JL, López F, Suárez C, Hermsen MA. Sinonasal carcinoma: Clinical, pathological, genetic and therapeutic advances. Nature Reviews Clinical Oncology. 2014;11(8):460–472.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Email this article 
